• Home
  • The Fundation
  • Contact
info@cefi.es 91 556 40 49 / 91 556 94 50
  • Spanish

  • Home
  • The Fundation
    • CEFI
    • Activities
      • Studies, Reports and Position Papers
      • Participation in the public comment process
    • News
  • Contact us
0

Everything you need to know about

news

publications

and courses

ADVERTISING MEDICINAL PRODUCTS IN THE INTERIM PERIOD BETWEEN MARKETING AUTHORISATION AND THE DECISION ON PRICING AND PUBLIC FUNDING

This paper analyses the promotion of medicines for human use that have already received marketing authorization, when the advertising is made before the resolution on pricing and inclusion in the Spanish National Health Service. This is an issue addressed by

Leer Más >>
16 November 2021

Promotion of Research through IP protection

Three of the most recognized experts on IP farma in Spain Ángel García Vidal, profesor de Derecho Mercantil de la Universidad de Santiago de Compostela y Consejero Académico de Gómez Acebo y Pombo, Kiko Carrión García de Parada, Abogado socio

Leer Más >>
28 October 2021

DEBATE ON ADVANCED THERAPIES AND BIOLOGICAL MEDICINAL PRODUCTS

Jorge Muñoz, Member of CEFI Board lead the debate on advanced therapies an biological medicinal products. Sol Ruíz, Jefe de División de Productos Biológicos, Terapias Avanzadas y Biotecnología de la Agencia Española de Medicamentos y Productos Sanitarios and Jordi Faus,

Leer Más >>
28 October 2021

Clinical Research and data protection debate

Interesting debate with Jesús Rubí, Adjunto a la Dirección de la Agencia Española de Protección de Datos, Amelia Martín Uranga, Responsable de la Plataforma de Medicamentos Innovadores de Farmaindustria and Lluis Alcover, Abogado de Faus y Moliner. Interestingf debate about main

Leer Más >>
27 October 2021

STRONG INTEREST IN OUR DISCUSSION ON OBSERVATIONAL STUDIES ON MEDICATIONS AND PATIENT SUPPORT PROGRAMMES

On 15 October we had an interesting discussion on Observational Studies on Medications and patient support programmes in the new regulations that aroused a lot of interest. More than 90 people participated in the session with strong participation in questions

Leer Más >>
27 October 2021
CEFI derecho farmaceútico

Advertising of medicinal products before a financing decision by the National Health System

Superior Court of Justice of the Basque Country, Judicial Review Chamber, Judgment 246/2021 of 30 June resolved positively on a question widely debated in the sector: the possibility of advertising medicinal products that have been approved for sale but have

Leer Más >>
27 October 2021

PHARMACEUTICAL LAW PUBLICATION nº 77

Considerations on  the  pricing system for medicinal products. Lourdes Fraguas Gadea Abuse of dominant position consisting on predatory prices. Spanish Competition Authority Astrazeneca inhalers Decision. Alfonso Gutiérrez Hernández and Alberto Pérez Hernández Public supply of medicines. Doctrine generated by the

Leer Más >>
27 October 2021

PHARMACEUTICAL LAW PUBLICATION nº 78 Available for purchase and download

The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol  Health Data 29 Playbook as a gvernance

Leer Más >>
27 October 2021

nº93 COMMUNICATIONS ON INDUSTRIAL PROPERTY AND COMPETITION LAW

Available for download. The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol  Health Data 29 Playbook

Leer Más >>
27 October 2021

PHARMACEUTICAL LAW COURSE -25TH ANIVERSARY- CLOSING SESSION

Rosa Romero Sánchez, Presidenta de la Comisión de Sanidad del Congreso de los Diputados and Katia Piñol, Presidenta de CEFI highlight the importance of holding this debate. Pharmaceutical sector and medicinal innovation are constantly searching for health improvement. We need

Leer Más >>
26 October 2021

PUBLIC PROCUREMENT OF MEDICINES

Alberto Dorrego. Abogado socio de Eversheds Sutherland claim for a specific regulación on public procurement for innovative medicines and vaccines. He also highlight the importance of price and hospital offers confidentiality Carme Briera, Cousel de Clifford Chance enter into a

Leer Más >>
25 October 2021

PRICE, FINANCING DECISION AND PATIENT ACCESS TO INNOVATIVE MEDICINES

Second week of the Pharmaceutical Law Course begin with one of the main issues for innovative medicines. Lead by Javier de Urquía Martí, member of CEFI Board we had as speakers: Jesús García Herrero, Jefe de la intervención de precios

Leer Más >>
24 October 2021

CEFI Pharmaceutical Law Course starts

Katia Piñol Torres, our President and Patricia Lacruz. Directora General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia del Ministerio de Sanidad at the opening of the course.  Nice speakers and more tan 180 attendees. This

Leer Más >>
23 October 2021
Derecho farmaceútico

Fantastic first session

With  Javier Castrodeza, Ex Secretario General de Sanidad y Catedrático de Medicina Preventiva y Salud Pública, Lourdes Fraguas, Abogada of Cousel Herbert Smith Freehills Spain, César Hernández, Jefe del Departamento de Medicamentos de Uso Humano de la Agencia Española de

Leer Más >>
22 October 2021

BIOMEDICINE AND COMPETITION LAW

We cant think in a best way to end  our 25th Pharmaceutical Law Course Aniversary . Moisés Ramírez, Patrono de CEFI together with Sergio Sinovas, Subdirector de Industria y Energía de la Dirección de Competencia de la CNMC, Borja Martínez

Leer Más >>
21 October 2021

DIGITAL, PROMOTION AND COMPLIANCE IN PHARMACEUTICAL SECTOR

In this panel we are going to talk about promotion, digital aspects and compliance. As Speakers: Silvia Martínez, Patrono de CEFI, Jose Zamarriego Izquierdo, Director de la Unidad de la Supervisión Deontológica de Farmandustria, Alejandro González, Abogado de Hoyng Rokh

Leer Más >>
20 October 2021

COMMUNICATIONS ON INDUSTRIAL PROPERTY AND COMPETITION LAW nº 92 Available for download and purchase.

Section One. Current Affairs Medicine in the courts in 2020. Jordi Faus, Xavier Moliner, Eduard Rodellar, Santiago Tomás, Anna Gerbolés, Lluís Alcover, Laura Marquès, Juan Martínez, and Joan Carles Bailach Data protection in the COVID-19 pandemic (Part II). Jesús Rubí

Leer Más >>
6 May 2021

PHARMACEUTICAL LAW PUBLICATION nº 76

Interruption of supply or the withdrawal of medicines from the market and competition rules. Henar González Durántez y Pilar Carrasco del Olmo   2021 versión of Pharmaceutical Industry Code  of Best Practices. Teresa Paz-Ares Rodríguez, Beatriz Cocina Arrieta y Nuria

Leer Más >>
6 May 2021

WORLD INTELLECTUAL PROPERTY DAY– 26 APRIL

In light of the current COVID-19 health crisis, it is an apt moment to highlight the importance of intellectual property. Intellectual and industrial property, among others, allow us to turn ideas into concrete projects that create value, wealth, jobs, and

Leer Más >>
26 April 2021

The two-part test for grant of supplementary protection certificates is here to stay, but at what price?

Commentary on the Royalty Pharma Ruling of the CJEU of 30 April 2020. Full text: Comunicaciones ENG oct 2020 pag     This post is also available in: Spanish

Leer Más >>
26 October 2020

CEFI Foundation submits its claims to the Draft Reference Price Order 2020

The reference price system and annual reference price orders are intended to contribute to the sustainability of the SNS. They should also promote the right balance between innovative generic/biosimilar, competition and competitiveness in the pharmaceutical and health market. Price decisions

Leer Más >>
16 October 2020

Cefi Foundation’s statements on the action plan to promote the use of drugs regulating the market in the National Health System

BIOSIMILAR AND GENERIC DRUGS With the document of statements, the CEFI Foundation analyses each of the specific measures proposed in the Plan in detail but, in general, it believes that in the draft of the plan, the basic principles of

Leer Más >>
10 March 2020

The worst discounts campaign

CEFI, as a member of the Interministerial Commission to act against activities which infringe intellectual and industrial property rights, backs the institutional anti-counterfeiting campaign carried out by the Ministry of Industry, Trade and Tourism together with the Spanish Patent and

Leer Más >>
10 March 2020

The value of brands

Farmaindustria has published an interesting decalogue on the value of brands. It is important to strengthen the role of brands as industrial property and business assets that strengthen competitiveness in the market and inform us about their attributes. They highlight

Leer Más >>
10 March 2020

This post is also available in: Spanish


  • A foundation for promoting and supporting research and technological development

    A foundation for promoting and supporting research and technological development, especially regarding the pharmaceutical industry

  • Address

    CEFI Fundation
    Avda. de Brasil, 17 9ºB
    Madrid 28020

    Find location

  • Information

    • Legal Notice
    • Privacy policy
    • Cookie policy
  • Contact

    +34 915 564 049
    +34 915 569 450
    info@cefi.es

  • Nuestra entidad se encuentra adherida a Confianza Online (Asociación sin ánimo de lucro), inscrita en el Registro Nacional de Asociaciones Grupo 1, Sección 1, número nacional 594400, CIF G85804011, Calle Carrera de San Jerónimo, 18 28014 Madrid (España).. Para más información: (confianzaonline.es).
  • Legal Notice
  • Privacy policy
  • Cookie policy
© 2020 Fundación CEFI | Todos los derechos reservados | Diseño by Bocetos